Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Little

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The New Zealand Medical Journal|August 8, 1979
Hay fever preventionE C Little
The New Zealand Medical Journal|February 25, 1976
Letter: Preventing allergies caused by airborne particlesE C Little, A L Odell
Journal of the American Optometric Association|June 1, 1986
Eye protection from airborne allergensE C Little, L F Garner
Oncogene|December 23, 2014
PAX3 and ETS1 synergistically activate MET expression in melanoma cellsJ D Kubic, E C Little, J W Lui, et al.
Oncogenesis|January 12, 2016
The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cellsE C Little, E R Camp, C Wang, et al.
Cancer Gene Therapy|March 9, 2013
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapyE R Camp, C Wang, E C Little, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The New Zealand Medical Journal|August 8, 1979
Hay fever preventionE C Little
The New Zealand Medical Journal|February 25, 1976
Letter: Preventing allergies caused by airborne particlesE C Little, A L Odell
Journal of the American Optometric Association|June 1, 1986
Eye protection from airborne allergensE C Little, L F Garner
Oncogene|December 23, 2014
PAX3 and ETS1 synergistically activate MET expression in melanoma cellsJ D Kubic, E C Little, J W Lui, et al.
Oncogenesis|January 12, 2016
The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cellsE C Little, E R Camp, C Wang, et al.
Cancer Gene Therapy|March 9, 2013
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapyE R Camp, C Wang, E C Little, et al.
Pageof 1